Showing results (641-650 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery and Synthesis of Novel Furan and Thiophene Sulfonamide-Based Derivatives as Dual-Functional α‑Glucosidase InhibitorsZeng Yi Fan, Si Tu Xiong, Song Hui Xu, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Quinazolinone Derivatives as Potent PARP1 InhibitorsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Novel Werner Syndrome RecQ DNA Helicase (WRN) Inhibitors for Cancer TreatmentXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Dimer-Dependent Aminoacrylamide Molecular Glues for 14-3-3 Protein-Protein InteractionsPaulo Pitasse-Santos, Marta Falcicchio, Rajdeep Sahota, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Fentanyl-Rewired: A 2‑Azaspiro[3.3]heptane Core Preserves μ‑Opioid FunctionArran W Stewart, Lisa M Eubanks, Mingliang Lin, et al.ACS Medicinal Chemistry Letters|April 20, 2023
Design, Synthesis, and Bioevaluation of Dexmedetomidine ProdrugXin Li, Jingjing Zhang, Changcui Zhou, et al.ACS Medicinal Chemistry Letters|April 20, 2023
Artefenomel Regioisomer RLA-3107 Is a Promising Lead for the Discovery of Next-Generation Endoperoxide AntimalarialsBrian R Blank, Jiri Gut, Philip J Rosenthal, et al.ACS Medicinal Chemistry Letters|April 20, 2023
Enhancing the Visibility of Women in the ACS Division of Medicinal Chemistry (ACS MEDI)Jane Aldrich, Shelley Allen, Erika Araujo, et al.ACS Medicinal Chemistry Letters|April 20, 2023
Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric DisordersRobert B KargboACS Medicinal Chemistry Letters|April 20, 2023
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric DisordersSimon Poulter, Nigel Austin, Rachel Armstrong, et al.Pageof 438